Gastrointestinal tolerability in primary care patients treated with naproxen or rofecoxib for osteoarthritis: the ADVANTAGE trial [Abstract] - Geba, GP (European League Against Rheumatism)
Prague, Czech Republic, June 13–16, 2001.